Iris Diaz-Boraschi
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Tendon properties in a mouse model of severe osteogenesis imperfecta.
Journal: Connective tissue research
Published: December 28, 2022
Effect of sclerostin inactivation in a mouse model of severe dominant osteogenesis imperfecta.
Journal: Scientific reports
Published: November 18, 2022
Data on body mass, glucose tolerance and bone phenotype of mice with osteogenesis imperfecta on long-term low-fat and high-fat diets.
Journal: Data in brief
Published: August 13, 2021
Skeletal Effects of Bone-Targeted TGFbeta Inhibition in a Mouse Model of Duchenne Muscular Dystrophy.
Journal: Life (Basel, Switzerland)
Published: June 30, 2021
Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta.
Journal: International journal of molecular sciences
Published: April 07, 2021
Muscle transcriptome in mouse models of osteogenesis imperfecta.
Journal: Bone
Published: February 24, 2021
Effects of treatment with a bone-targeted prostaglandin E2 receptor 4 agonist C3 (Mes-1007) in a mouse model of severe osteogenesis imperfecta.
Journal: Bone
Published: December 27, 2020
Male but not female mice with severe osteogenesis imperfecta are partially protected from high-fat diet-induced obesity.
Journal: Molecular genetics and metabolism
Published: November 23, 2020
Collagen type I degradation fragments act through the collagen receptor LAIR-1 to provide a negative feedback for osteoclast formation.
Journal: Bone
Published: May 11, 2018
Metabolic phenotype in the mouse model of osteogenesis imperfecta.
Journal: The Journal of endocrinology
Published: July 11, 2017
Fibrillin-1 directly regulates osteoclast formation and function by a dual mechanism.
Journal: Journal of cell science
Published: September 17, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026